Photothermal Iron‐Based Riboflavin Microneedles for the Treatment of Bacterial Keratitis via Ion Therapy and Immunomodulation

Author:

Zhou Jun12,Zhang Lisha2,Wei Yaqi1,Wu Qiang12,Mao Kaibo1,Wang Xiaoli1,Cai Jinfeng1,Li Xia1,Jiang Yongxiang3ORCID

Affiliation:

1. Department of Ophthalmology Shanghai Aier Eye Hospital Shanghai P. R. China

2. Department of Ophthalmology Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai Jiao Tong University Shanghai 200233 China

3. Eye Institute and Department of Ophthalmology Eye & ENT Hospital Fudan University Shanghai 200031 China

Abstract

AbstractBacterial biofilm formation protects bacteria from antibiotics and the immune system, excessive inflammation further complicates treatment. Here, iron‐based metal–organic framework (MIL‐101)‐loaded riboflavin nanoparticles are designed for the therapeutic challenge of biofilm infection and hyperinflammation in bacterial keratitis. Specifically, MIL‐101 produces a thermal effect under exogenous near‐infrared light irradiation, which synergizes with ferroptosis‐like bacterial death induced by iron ions to exert an effective biofilm infection eradication effect. On the other hand, the disintegration of MIL‐101 sustains the release of riboflavin, which inhibits the pro‐inflammatory response of macrophage over‐activation by modulating their phenotypic switch. In addition, to solve the problems of short residence time, poor permeability, and low bioavailability of corneal medication, the MR@MN microneedle patch is further prepared by loading nanoparticles into SilMA hydrogel, which ultimately achieves painless, transepithelial, and highly efficient drug delivery. In vivo and ex vivo experiments demonstrate the effectiveness of this approach in eliminating bacterial infection and promoting corneal healing. Therefore, the MRMN patch, acting as an ocular drug delivery system with the ability of rapid corneal healing, promises a cost‐effective solution for the treatment of bacterial keratitis, which may also lead to a new approach for treating bacterial keratitis in clinics.

Funder

National Natural Science Foundation of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3